Revenue
9.68 thousand USD
2024 Q2 · USD
Exact inputs and evidence
- Revenue: 9684 USD Source
Market value is not computed: no recent price is available.
7 filing records in this dataset, filed from 2022-01-21 to 2024-02-13. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
9.68 thousand USD
2024 Q2 · USD
-27,050.05%
2024 Q2 · %
-331 thousand USD
2024 Q2 · USD
237614 USD
17646296 shares
68.97% · 7.2 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-11.3 million USD
2023-01-01 – 2023-12-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-02-13.
Financial data available through: 2023-06-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 5.86 million
–
Current period
−USD 8.99 million
–
-8988456 − -5856116 = -3132340 USD
-5856116 USD · 2021-07-01 – 2022-06-30
Inspect prior input Prior source-8988456 USD · 2022-07-01 – 2023-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 2.42 million
–
Current period
−USD 4.27 million
–
-4266353 − -2418422 = -1847931 USD
-2418422 USD · 2021-07-01 – 2022-06-30
Inspect prior input Prior source-4266353 USD · 2022-07-01 – 2023-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2022-07-01 – 2023-06-30 | 7048 | 5851231 Derived | -5844183 | 3144273 Derived | -8988456 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 7048 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -82,919.7% |
|
| 2023 | Net margin | -127,532% |
|
| 2023 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -4266353 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 46.7% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 1.41× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2021-07-01 – 2022-06-30 | −USD 5.86 million Exact valueExact value: -5856116 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.42 million Exact valueExact value: -2418422 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-07-01 – 2023-06-30 | −USD 8.99 million Exact valueExact value: -8988456 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.27 million Exact valueExact value: -4266353 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
7 filings · 371 latest values · 371 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001865127, 1865127, LSDI, edgar:1865127
Also known as Lucy Scientific Discovery Inc., Lucy Scientific Discovery, Inc.